Effect of Ferula Assafoetida on polycystic ovarian syndrome

Phase 3

Recruiting

• Conditions: Polycystic ovarian syndrome.; Polycystic ovarian syndrome; E28.2

• Registration Number: IRCT20190728044360N1
• Lead Sponsor: Shahed University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 17 December 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 30

Inclusion Criteria

All 15 to 40 years old women with polycystic ovarian syndrome

Exclusion Criteria

Pregnancy
Allergy to Ferula Asafoetida
Diabetic patients
Thyroid diseases

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Presence of ovarian cysts. Timepoint: Before Intervention and seven days after Intervention. Method of measurement: Sonography.;Occurrence of menstrual bleeding. Timepoint: 4 and 8 weeks after the beginning of treatment. Method of measurement: asking.;Hirsutism. Timepoint: Before Intervention and seven days after Intervention. Method of measurement: Ferriman–Gallwey scale.

Secondary Outcome Measures

Name	Time	Method
Body mass index. Timepoint: Before Intervention and seven days after Intervention. Method of measurement: Meter and scale.;Total Testosterone. Timepoint: Before Intervention and seven days after Intervention. Method of measurement: CLIA laboratory method.;Free Testosterone. Timepoint: Before Intervention and seven days after Intervention. Method of measurement: ELIZA laboratory method.